Open AccessATIM-37. SAFETY RUN-IN RESULTS OF A PHASE I/II STUDY TO EVALUATE THE SAFETY AND CLINICAL EFFICACY OF ATEZOLIZUMAB (ATEZO; aPDL1) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
Author(s) -
ShiaoPei Weathers,
Carlos Kamiya-Matsuoka,
Shan Dervin,
Cindy Yun,
Monica Loghin,
Barbara O’Brien,
Rebecca A. Harrison,
W.K. Alfred Yung,
Marta PenasPrado,
John de Groot
Publication year - 2018
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/noy148.032
Subject(s) - medicine , temozolomide , oncology , adjuvant , atezolizumab , radiation therapy , dexamethasone , surgery , cancer , immunotherapy , nivolumab
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom